AbbVie Inc.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psori…
Drug Manufacturers - General
US, North Chicago [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peer Group Analysis
Similar Stocks · Benchmarked Analysis · Peer GroupA quick analysis that compared AbbVie Inc. (ABBV) to it's peer group, including competitors as well as it's industry. All monetary values in mil. except volume - volume is in thousands.
| Company | Price | Change | Volume, Avg. | Market Cap. | Revenue | Profit Net | Earnings | Free Cash Flow | Dividend Yield | P/E | EPS | Gross Margin % | Net Margin % | ROE % | ROA % | Quick Ratio % | Shares Outstanding | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Drug Manufacturers—General Average | - - | - - | - - | 52,546.59 | 5,673.25 | 784.38 | 4,046.86 | 126.36 | 0.01 | -6.6776 | 0.62 | 0.5586 | 0.0059 | 0.00 | 0.07 | 2.4063 | - - | ||
| Maximum | - - | - - | - - | 197,802.00 | 13,765.00 | 2,179.00 | 18,021.00 | 1,294.00 | 0.04 | 46.2856 | 2.71 | 0.7672 | 0.2203 | 0.03 | 0.53 | 21.1421 | - - | ||
| Minimum | - - | - - | - - | 0.00 | 77.00 | -82.00 | -1,283.00 | -2,626.00 | 0.00 | -311.9276 | -0.15 | 0.0683 | -0.9021 | -0.08 | -0.04 | 0.0000 | - - | ||
| AbbVie Inc. ABBV | 171.69 | 3.93 2.34% | 2,882 vs. 5,440 | 303,391.00 | 12,310.00 | 1,369.00 | 3,847.00 | -2,384.00 | 0.7700 | 58.3938 | 0.0087 | 0.6684 | 0.1112 | 0.1710 | 0.0092 | 0.7229 | 1,767.00 | ||
| Gilead Sciences, Inc. GILD | 89.77 | 1.14 1.29% | 1,459 vs. 6,733 | 111,878.00 | 6,686.00 | -4,170.00 | 2,114.00 | 10,656.00 | -3.3400 | -5.4485 | 0.0109 | 0.7679 | -0.6237 | -0.2378 | -0.0741 | 0.8243 | 1,246.00 | ||
| Bristol-Myers Squibb Company BMY | 58.20 | 0.32 0.55% | 2,928 vs. 11,052 | 118,040.00 | 11,865.00 | -11,911.00 | 2,550.00 | 15,640.00 | -5.8900 | -2.2500 | 0.0113 | 0.7529 | -1.0039 | -0.7223 | -0.1203 | 0.9190 | 2,028.00 | ||
| Pfizer Inc. PFE | 25.16 | 0.23 0.90% | 18,588 vs. 36,462 | 142,609.00 | 14,879.00 | 3,115.00 | 387.00 | 121,318.00 | 0.5500 | 12.5852 | 0.0151 | 0.7056 | 0.2094 | 0.0338 | 0.0141 | 0.5659 | 5,666.00 | ||
| Amgen Inc. AMGN | 289.54 | 1.67 0.58% | 1,187 vs. 2,169 | 155,634.00 | 7,396.00 | -113.00 | 459.00 | -27,870.00 | -0.2100 | -335.6404 | 0.0080 | 0.5673 | -0.0153 | -0.0225 | -0.0012 | 0.8362 | 537.00 | ||
| Eli Lilly and Company LLY | 748.10 | -5.31 -0.70% | 2,023 vs. 3,396 | 710,183.00 | 8,768.00 | 2,242.00 | 179.00 | 12,553.00 | 2.4900 | 76.3636 | 0.0017 | 0.8250 | 0.2558 | 0.1751 | 0.0351 | 0.6775 | 949.00 | ||
| Merck & Co., Inc. MRK | 99.22 | 1.78 1.82% | 5,657 vs. 9,695 | 250,978.00 | 15,809.00 | 4,762.00 | 2,229.00 | 56,697.00 | 1.8800 | 17.4190 | 0.0059 | 0.7511 | 0.3012 | 0.1180 | 0.0450 | 0.7284 | 2,529.00 | ||
| Johnson & Johnson JNJ | 155.38 | 2.27 1.48% | 3,227 vs. 6,343 | 374,083.00 | 21,382.00 | 3,255.00 | 2,850.00 | 153,378.00 | 1.3500 | 29.1832 | 0.0076 | 0.6878 | 0.1522 | 0.0465 | 0.0189 | 0.8448 | 2,407.00 | ||
More Due Diligence
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.